Chih Kang Ke

Director/Board Member en TAHO PHARMACEUTICALS LTD .

Health Technology

Finance

Producer Manufacturing

Perfil

Chih Kang Ke is an Independent Director at TAHO Pharmaceuticals Ltd.
He previously worked as a Managing Director & Investment Director at Global Strategic Investment Management, Inc., an Independent Director at Easywell Biomedicals, Inc., an Independent Director at MACHVISION, Inc., and a Member-Supervisory Board at PharmaDax Inc.

Cargos activos de Chih Kang Ke

Empresas	Cargo	Inicio
TAHO PHARMACEUTICALS LTD	Director/Board Member	-

Todos los cargos activos de Chih Kang Ke

Antiguos cargos conocidos de Chih Kang Ke.

Empresas	Cargo	Fin
EASYWELL BIOMEDICALS, INC.	Director/Board Member	-
MACHVISION INC.	Director/Board Member	-
PHARMADAX INC.	Director/Board Member	-
Global Strategic Investment Management, Inc.	Chief Executive Officer	-

Ver el detalle de la experiencia de Chih Kang Ke.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Chih Kang Ke.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
EASYWELL BIOMEDICALS, INC.	Health Technology
MACHVISION INC.	Producer Manufacturing

Empresas privadas	3
Global Strategic Investment Management, Inc.	Finance
PharmaDax Inc. PharmaDax Inc. Pharmaceuticals: MajorHealth Technology PharmaDax Inc. engages in the development and marketing of generic dossiers. Its products include Glyburide, Quetiapine Fumarate ER, and Metoprolol Succinate ER tablets. The company was founded by Yi Pin Huang on March 21, 2008 and is headquartered in New Taipei, Taiwan.	Health Technology
TAHO Pharmaceuticals Ltd. TAHO Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Taho Pharmaceuticals Ltd. engages in the research and development of pharmaceutical products. Its Technology Platform products are the Transepithelial Delivery System, Transdermal DDS, Transmucosal SSD, and Bio-Revie. The firm's Research & Development products include medicines for migraine, alzheimer's disease, hyperactivity disorder, and nausea caused by chemotherapy. The company was founded on July 7, 2010 and is headquartered in Taipei, Taiwan.	Health Technology

Ver las conexiones de la empresa